Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1992;23:1643-1650

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siren, A. L.
Right arrow Articles by Hallenbeck, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siren, A. L.
Right arrow Articles by Hallenbeck, J. M.

Stroke, Vol 23, 1643-1650, Copyright © 1992 by American Heart Association


ARTICLES

Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats

AL Siren, E Heldman, D Doron, PG Lysko, TL Yue, Y Liu, G Feuerstein and JM Hallenbeck
Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814.

BACKGROUND AND PURPOSE: We reported previously that stroke risk factors prepared the brain stem for the development of ischemia and hemorrhage and induced the production of tumor necrosis factor following an intrathecal injection of lipopolysaccharide, a prototypic monocyte- activating stimulus. This study evaluates whether blood or brain cells of hypertensive rats produce more proinflammatory and prothrombotic mediators than do blood or brain cells of normotensive rats. METHODS: Levels of tumor necrosis factor, platelet-activating factor, 6- ketoprostaglandin F1 alpha, and thromboxane B2 in the cerebrospinal fluid and blood of spontaneously hypertensive and normotensive Wistar- Kyoto rats were monitored before and after a challenge with lipopolysaccharide. RESULTS: Little or no activity from these mediators was found in the cerebrospinal fluid or blood of saline-injected control animals. Intravenous administration of lipopolysaccharide (0.001, 0.1, and 1.8 mg/kg) produced dose-dependent increases in blood levels of all mediators in hypertensive rats. In normotensive rats the levels were less than in hypertensive rats and were not clearly dose- related. When lipopolysaccharide was injected intracerebroventricularly, more tumor necrosis factor was measured in the cerebrospinal fluid than in the blood, suggesting local synthesis of this cytokine. Levels of tumor necrosis factor and platelet- activating factor in the cerebrospinal fluid were higher in hypertensive than in normotensive rats. The thromboxane A2/prostacyclin ratio was not altered significantly between the two rat strains. CONCLUSIONS: It is suggested that the higher incidence of brain stem ischemia and hemorrhage after the intrathecal injection of lipopolysaccharide in hypertensive rats than in normotensive rats might be related to the higher levels of the two cytotoxic factors tumor necrosis factor and platelet-activating factor produced in response to such challenge.


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
M. A. Sardo, M. Castaldo, M. Cinquegrani, M. Bonaiuto, L. Fontana, S. Campo, G. M. Campo, D. Altavilla, and A. Saitta
Effects of AT1 Receptor Antagonist Losartan on sICAM-1 and TNF-a Levels in Uncomplicated Hypertensive Patients
Angiology, March 1, 2004; 55(2): 195 - 203.
[Abstract] [PDF]


Home page
HypertensionHome page
L. Marks, H. V.O. Carswell, E. E. Peters, D. I. Graham, J. Patterson, A. F. Dominiczak, and I. M. Macrae
Characterization of the Microglial Response to Cerebral Ischemia in the Stroke-Prone Spontaneously Hypertensive Rat
Hypertension, July 1, 2001; 38(1): 116 - 122.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. J. DeGraba, A.-L. Siren, L. Penix, R. M. McCarron, R. Hargraves, S. Sood, K. D. Pettigrew, and J. M. Hallenbeck
Increased Endothelial Expression of Intercellular Adhesion Molecule-1 in Symptomatic Versus Asymptomatic Human Carotid Atherosclerotic Plaque
Stroke, July 1, 1998; 29(7): 1405 - 1410.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Bernard, R. Merval, B. Esposito, and A. Tedgui
Resistance to Endotoxin Shock in Spontaneously Hypertensive Rats
Hypertension, June 1, 1998; 31(6): 1350 - 1356.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. E. Brian Jr, F. M. Faraci, and G. Feuerstein
Tumor Necrosis Factor-{alpha}–Induced Dilatation of Cerebral Arterioles • Editorial Comment
Stroke, February 1, 1998; 29(2): 509 - 515.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. C. Barone, B. Arvin, R. F. White, A. Miller, C. L. Webb, R. N. Willette, P. G. Lysko, and G. Z. Feuerstein
Tumor Necrosis Factor-{alpha} : A Mediator of Focal Ischemic Brain Injury
Stroke, June 1, 1997; 28(6): 1233 - 1244.
[Abstract] [Full Text]


Home page
StrokeHome page
X. Wang, T.-L. Yue, F. C. Barone, and G. Z. Feuerstein
Monocyte Chemoattractant Protein–1 Messenger RNA Expression in Rat Ischemic Cortex
Stroke, April 1, 1995; 26(4): 661 - 666.
[Abstract] [Full Text]